Compare IRON & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | DRD |
|---|---|---|
| Founded | 2017 | 1895 |
| Country | United States | South Africa |
| Employees | N/A | 3410 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.4B |
| IPO Year | 2020 | N/A |
| Metric | IRON | DRD |
|---|---|---|
| Price | $66.38 | $38.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $99.54 | $32.63 |
| AVG Volume (30 Days) | ★ 943.0K | 313.9K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.62% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $35.87 |
| Revenue Next Year | $215.03 | $23.22 |
| P/E Ratio | ★ N/A | $15.32 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $30.82 | $11.67 |
| 52 Week High | $99.50 | $39.37 |
| Indicator | IRON | DRD |
|---|---|---|
| Relative Strength Index (RSI) | 43.58 | 59.93 |
| Support Level | $57.45 | $29.93 |
| Resistance Level | $82.70 | $39.37 |
| Average True Range (ATR) | 6.10 | 1.57 |
| MACD | 0.27 | 0.36 |
| Stochastic Oscillator | 73.52 | 89.56 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.